These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 25445363)

  • 1. Role of Drosophila calcium channel cacophony in dopaminergic neurodegeneration and neuroprotection.
    Wiemerslage L; Lee D
    Neurosci Lett; 2015 Jan; 584():342-6. PubMed ID: 25445363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective degeneration of dopaminergic neurons by MPP(+) and its rescue by D2 autoreceptors in Drosophila primary culture.
    Wiemerslage L; Schultz BJ; Ganguly A; Lee D
    J Neurochem; 2013 Aug; 126(4):529-40. PubMed ID: 23452092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early alterations of mitochondrial morphology in dopaminergic neurons from Parkinson's disease-like pathology and time-dependent neuroprotection with D2 receptor activation.
    Wiemerslage L; Ismael S; Lee D
    Mitochondrion; 2016 Sep; 30():138-47. PubMed ID: 27423787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nobiletin protects dopaminergic neurons in the 1-methyl-4-phenylpyridinium-treated rat model of Parkinson's disease.
    Jeong KH; Jeon MT; Kim HD; Jung UJ; Jang MC; Chu JW; Yang SJ; Choi IY; Choi MS; Kim SR
    J Med Food; 2015 Apr; 18(4):409-14. PubMed ID: 25325362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional microglia are transcriptionally distinct but similarly exacerbate neurodegeneration in a culture model of Parkinson's disease.
    Kostuk EW; Cai J; Iacovitti L
    J Neuroinflammation; 2018 May; 15(1):139. PubMed ID: 29751760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disruption of dopamine homeostasis underlies selective neurodegeneration mediated by alpha-synuclein.
    Park SS; Schulz EM; Lee D
    Eur J Neurosci; 2007 Dec; 26(11):3104-12. PubMed ID: 18005066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered ER-mitochondria contact impacts mitochondria calcium homeostasis and contributes to neurodegeneration in vivo in disease models.
    Lee KS; Huh S; Lee S; Wu Z; Kim AK; Kang HY; Lu B
    Proc Natl Acad Sci U S A; 2018 Sep; 115(38):E8844-E8853. PubMed ID: 30185553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secalonic acid A protects dopaminergic neurons from 1-methyl-4-phenylpyridinium (MPP⁺)-induced cell death via the mitochondrial apoptotic pathway.
    Zhai A; Zhu X; Wang X; Chen R; Wang H
    Eur J Pharmacol; 2013 Aug; 713(1-3):58-67. PubMed ID: 23665112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium, ageing, and neuronal vulnerability in Parkinson's disease.
    Surmeier DJ
    Lancet Neurol; 2007 Oct; 6(10):933-8. PubMed ID: 17884683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Apamin on MPP
    Park J; Jang KM; Park KK
    Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotective effect of damaurone D in a C. elegans model of Parkinson's disease.
    Lee SH; Han YT; Cha DS
    Neurosci Lett; 2021 Mar; 747():135623. PubMed ID: 33482307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutant PINK1 upregulates tyrosine hydroxylase and dopamine levels, leading to vulnerability of dopaminergic neurons.
    Zhou ZD; Refai FS; Xie SP; Ng SH; Chan CH; Ho PG; Zhang XD; Lim TM; Tan EK
    Free Radic Biol Med; 2014 Mar; 68():220-33. PubMed ID: 24374372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemically administered neuregulin-1β1 rescues nigral dopaminergic neurons via the ErbB4 receptor tyrosine kinase in MPTP mouse models of Parkinson's disease.
    Depboylu C; Rösler TW; de Andrade A; Oertel WH; Höglinger GU
    J Neurochem; 2015 May; 133(4):590-7. PubMed ID: 25581060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylphenylpyridium ion (MPP+) enhances glutamate-induced cytotoxicity against dopaminergic neurons in cultured rat mesencephalon.
    Sawada H; Shimohama S; Tamura Y; Kawamura T; Akaike A; Kimura J
    J Neurosci Res; 1996 Jan; 43(1):55-62. PubMed ID: 8838574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Chinese herbal formula Liuwei dihuang protects dopaminergic neurons against Parkinson's toxin through enhancing antioxidative defense and preventing apoptotic death.
    Tseng YT; Chang FR; Lo YC
    Phytomedicine; 2014 Apr; 21(5):724-33. PubMed ID: 24411708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The iron-binding protein lactoferrin protects vulnerable dopamine neurons from degeneration by preserving mitochondrial calcium homeostasis.
    Rousseau E; Michel PP; Hirsch EC
    Mol Pharmacol; 2013 Dec; 84(6):888-98. PubMed ID: 24077968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naringin protects the nigrostriatal dopaminergic projection through induction of GDNF in a neurotoxin model of Parkinson's disease.
    Leem E; Nam JH; Jeon MT; Shin WH; Won SY; Park SJ; Choi MS; Jin BK; Jung UJ; Kim SR
    J Nutr Biochem; 2014 Jul; 25(7):801-6. PubMed ID: 24797334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homer1 knockdown protects dopamine neurons through regulating calcium homeostasis in an in vitro model of Parkinson's disease.
    Chen T; Yang YF; Luo P; Liu W; Dai SH; Zheng XR; Fei Z; Jiang XF
    Cell Signal; 2013 Dec; 25(12):2863-70. PubMed ID: 24036210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gremlin is a novel VTA derived neuroprotective factor for dopamine neurons.
    Phani S; Jablonski M; Pelta-Heller J; Cai J; Iacovitti L
    Brain Res; 2013 Mar; 1500():88-98. PubMed ID: 23348379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using human pluripotent stem cell-derived dopaminergic neurons to evaluate candidate Parkinson's disease therapeutic agents in MPP+ and rotenone models.
    Peng J; Liu Q; Rao MS; Zeng X
    J Biomol Screen; 2013 Jun; 18(5):522-33. PubMed ID: 23364514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.